a Institute of Hepatobiliary Surgery, Southwest Hospital , Third Military Medical University , Chongqing , P.R. China.
Int J Hyperthermia. 2017 Nov;33(7):846-852. doi: 10.1080/02656736.2017.1303752. Epub 2017 Mar 23.
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) has high morbidity and mortality. In this study, the safety and efficacy of a modification of ALPPS (radiofrequency-assisted ALPPS, RALPPS) were assessed in patients with hepatocellular carcinoma (HCC).
Patients who were diagnosed with HCC and were considered to have an insufficient future liver remnant (FLR) were enrolled. In stage I, a radiofrequency ablation (RFA) device was used to cauterise along the planned transection plane to form a coagulum avascular area. When the FLR reached above 40%, hepatectomy was performed in stage II along the coagulum area established previously. After two stages, operative morbidity, mortality, per cent increase in FLR, operative time and blood loss were evaluated.
Between July 2014 and September 2015, 10 patients with HCC (9 with hepatitis-related cirrhosis) were treated with the RALPPS procedure. The incidence of severe complications (Clavien-Dindo ≥ IIIb) was 20% (2/10). One patient died. No biliary leakage, intraperitoneal infection or post-hepatectomy liver failure (PHLF) occurred after both stages. The median FLR before stage I was 31% (364 ml). This increased to 47% (632 ml) before stage II after a median interval of 28 days. The median percentage increase in FLR was 53% (210 ml). Additionally, the median operative time during the first and second stages was 214 and 281 min, respectively. The corresponding median blood loss was 200 and 550 ml, respectively.
RALPPS has a potential advantage in eliminating serious complications of biliary leakage and PHLF associated with classic ALPPS. On the basis of rigorous patient selection criteria, RALPPS may achieve the same effect of promoting significant growth of the FLR in patients with cirrhosis-related HCC and insufficient FLR volume, albeit at the cost of a longer interval time.
联合肝脏离断和门静脉结扎的二步肝切除术(ALPPS)具有较高的发病率和死亡率。本研究评估了射频辅助 ALPPS(RALPPS)改良术式治疗肝细胞癌(HCC)的安全性和有效性。
纳入诊断为 HCC 且预计未来剩余肝脏(FLR)不足的患者。在第一阶段,使用射频消融(RFA)设备沿计划的肝断面烧灼形成一个无血管的凝血块区域。当 FLR 达到 40%以上时,在第二阶段沿先前建立的凝血块区域行肝切除术。完成两个阶段后,评估手术发病率、死亡率、FLR 增加百分比、手术时间和出血量。
2014 年 7 月至 2015 年 9 月,10 例 HCC 患者(9 例伴有肝炎相关肝硬化)接受了 RALPPS 手术。严重并发症(Clavien-Dindo≥IIIb)发生率为 20%(2/10)。1 例患者死亡。两阶段后均未发生胆漏、腹腔感染或术后肝功能衰竭(PHLF)。第一阶段前 FLR 中位数为 31%(364ml)。中位间隔 28 天后第二阶段前 FLR 增加至 47%(632ml)。FLR 中位数增加百分比为 53%(210ml)。此外,第一阶段和第二阶段的中位手术时间分别为 214min 和 281min,相应的中位出血量分别为 200ml 和 550ml。
RALPPS 在消除经典 ALPPS 相关胆漏和 PHLF 等严重并发症方面具有潜在优势。在严格的患者选择标准基础上,RALPPS 可能会使伴有肝硬化的 HCC 患者和预计 FLR 体积不足的患者获得相同的促进 FLR 显著增长的效果,尽管需要更长的时间间隔。